{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:23:38Z","timestamp":1782285818448,"version":"3.54.5"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T00:00:00Z","timestamp":1425427200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s00467-015-3069-7","type":"journal-article","created":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T22:18:39Z","timestamp":1425421119000},"page":"195-206","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["From skeletal to cardiovascular disease in 12 steps\u2014the evolution of sclerostin as a major player in CKD-MBD"],"prefix":"10.1007","volume":"31","author":[{"given":"Vincent M.","family":"Brandenburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"D\u2019Haese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Deck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djalila","family":"Mekahli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Meijers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Neven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Evenepoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,4]]},"reference":[{"key":"3069_CR1","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1098\/rstb.2007.2251","volume":"363","author":"HA Kestler","year":"2008","unstructured":"Kestler HA, Kuhl M (2008) From individual Wnt pathways towards a Wnt signalling network. Philos Trans R Soc Lond B Biol Sci 363:1333\u20131347","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"3069_CR2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1042\/BJ20121284","volume":"450","author":"W Kim","year":"2013","unstructured":"Kim W, Kim M, Jho EH (2013) Wnt\/beta-catenin signalling: from plasma membrane to nucleus. Biochem J 450:9\u201321","journal-title":"Biochem J"},{"key":"3069_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2011.10.044","volume":"492","author":"DG Monroe","year":"2012","unstructured":"Monroe DG, McGee-Lawrence ME, Oursler MJ, Westendorf JJ (2012) Update on Wnt signaling in bone cell biology and bone disease. Gene 492:1\u201318","journal-title":"Gene"},{"key":"3069_CR4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1297\/cpe.19.49","volume":"19","author":"T Kubota","year":"2010","unstructured":"Kubota T, Michigami T, Ozono K (2010) Wnt signaling in bone. Clin Pediatr Endocrinol 19:49\u201356","journal-title":"Clin Pediatr Endocrinol"},{"key":"3069_CR5","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1126\/science.1136370","volume":"315","author":"A Mani","year":"2007","unstructured":"Mani A, Radhakrishnan J, Wang H, Mani A, Mani MA, Nelson-Williams C, Carew KS, Mane S, Najmabadi H, Wu D, Lifton RP (2007) LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 315:1278\u20131282","journal-title":"Science"},{"key":"3069_CR6","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/CIRCRESAHA.110.223750","volume":"107","author":"E Dejana","year":"2010","unstructured":"Dejana E (2010) The role of Wnt signaling in physiological and pathological angiogenesis. Circ Res 107:943\u2013952","journal-title":"Circ Res"},{"key":"3069_CR7","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/BOR.0b013e32816e06f9","volume":"19","author":"ML Johnson","year":"2007","unstructured":"Johnson ML, Kamel MA (2007) The Wnt signaling pathway and bone metabolism. Curr Opin Rheumatol 19:376\u2013382","journal-title":"Curr Opin Rheumatol"},{"key":"3069_CR8","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/jcb.23182","volume":"112","author":"NM Rajamannan","year":"2011","unstructured":"Rajamannan NM (2011) The role of Lrp5\/6 in cardiac valve disease: LDL-density-pressure theory. J Cell Biochem 112:2222\u20132229","journal-title":"J Cell Biochem"},{"key":"3069_CR9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2213-8587(14)70059-2","volume":"2","author":"MG Vervloet","year":"2014","unstructured":"Vervloet MG, Massy ZA, Brandenburg VM, Mazzaferro S, Cozzolino M, Urena-Torres P, Bover J, Goldsmith D (2014) Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders. Lancet Diabetes Endocrinol 2:427\u2013436","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3069_CR10","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/ndt\/gft514","volume":"29","author":"M Cozzolino","year":"2014","unstructured":"Cozzolino M, Urena-Torres P, Vervloet MG, Brandenburg V, Bover J, Goldsmith D, Larsson TE, Massy ZA, Mazzaferro S (2014) Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome? Nephrol Dial Transplant 29:1815\u20131820","journal-title":"Nephrol Dial Transplant"},{"key":"3069_CR11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1210\/er.2011-1060","volume":"33","author":"HZ Ke","year":"2012","unstructured":"Ke HZ, Richards WG, Li X, Ominsky MS (2012) Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases. Endocr Rev 33:747\u2013783","journal-title":"Endocr Rev"},{"key":"3069_CR12","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","volume":"22","author":"DG Winkler","year":"2003","unstructured":"Winkler DG, Sutherland MK, Geoghegan JC, Yu C, Hayes T, Skonier JE, Shpektor D, Jonas M, Kovacevich BR, Staehling-Hampton K, Appleby M, Brunkow ME, Latham JA (2003) Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J 22:6267\u20136276","journal-title":"EMBO J"},{"key":"3069_CR13","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1096\/fj.05-4221fje","volume":"19","author":"KE Poole","year":"2005","unstructured":"Poole KE, van Bezooijen RL, Loveridge N, Hamersma H, Papapoulos SE, Lowik CW, Reeve J (2005) Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J 19:1842\u20131844","journal-title":"FASEB J"},{"key":"3069_CR14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.abb.2014.05.003","volume":"561","author":"M Capulli","year":"2014","unstructured":"Capulli M, Paone R, Rucci N (2014) Osteoblast and osteocyte: games without frontiers. Arch Biochem Biophys 561:3\u201312","journal-title":"Arch Biochem Biophys"},{"key":"3069_CR15","doi-asserted-by":"crossref","first-page":"20764","DOI":"10.1073\/pnas.0805133106","volume":"105","author":"L Pederson","year":"2008","unstructured":"Pederson L, Ruan M, Westendorf JJ, Khosla S, Oursler MJ (2008) Regulation of bone formation by osteoclasts involves Wnt\/BMP signaling and the chemokine sphingosine-1-phosphate. Proc Natl Acad Sci U S A 105:20764\u201320769","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3069_CR16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11914-007-0006-0","volume":"5","author":"R Baron","year":"2007","unstructured":"Baron R, Rawadi G (2007) Wnt signaling and the regulation of bone mass. Curr Osteoporos Rep 5:73\u201380","journal-title":"Curr Osteoporos Rep"},{"key":"3069_CR17","doi-asserted-by":"crossref","first-page":"e7930","DOI":"10.1371\/journal.pone.0007930","volume":"4","author":"HY Choi","year":"2009","unstructured":"Choi HY, Dieckmann M, Herz J, Niemeier A (2009) Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo. PLoS One 4:e7930","journal-title":"PLoS One"},{"key":"3069_CR18","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.devcel.2005.02.017","volume":"8","author":"DA Glass","year":"2005","unstructured":"Glass DA, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H, Taketo MM, Long F, McMahon AP, Lang RA, Karsenty G (2005) Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8:751\u2013764","journal-title":"Dev Cell"},{"key":"3069_CR19","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.cellsig.2013.07.005","volume":"25","author":"Y Schmitz","year":"2013","unstructured":"Schmitz Y, Rateitschak K, Wolkenhauer O (2013) Analysing the impact of nucleo-cytoplasmic shuttling of beta-catenin and its antagonists APC, Axin and GSK3 on Wnt\/beta-catenin signalling. Cell Signal 25:2210\u20132221","journal-title":"Cell Signal"},{"key":"3069_CR20","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa013444","volume":"346","author":"LM Boyden","year":"2002","unstructured":"Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP (2002) High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346:1513\u20131521","journal-title":"N Engl J Med"},{"key":"3069_CR21","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1359\/jbmr.2003.18.6.960","volume":"18","author":"P Babij","year":"2003","unstructured":"Babij P, Zhao W, Small C, Kharode Y, Yaworsky PJ, Bouxsein ML, Reddy PS, Bodine PV, Robinson JA, Bhat B, Marzolf J, Moran RA, Bex F (2003) High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res 18:960\u2013974","journal-title":"J Bone Miner Res"},{"key":"3069_CR22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/jmg.39.2.91","volume":"39","author":"W Balemans","year":"2002","unstructured":"Balemans W, Patel N, Ebeling M, Van Hul E, Wuyts W, Lacza C, Dioszegi M, Dikkers FG, Hildering P, Willems PJ, Verheij JB, Lindpaintner K, Vickery B, Foernzler D, Van Hul W (2002) Identification of a 52\u00a0kb deletion downstream of the SOST gene in patients with van Buchem disease. J Med Genet 39:91\u201397","journal-title":"J Med Genet"},{"key":"3069_CR23","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1359\/jbmr.060311","volume":"21","author":"F Morvan","year":"2006","unstructured":"Morvan F, Boulukos K, Clement-Lacroix P, Roman RS, Suc-Royer I, Vayssiere B, Ammann P, Martin P, Pinho S, Pognonec P, Mollat P, Niehrs C, Baron R, Rawadi G (2006) Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res 21:934\u2013945","journal-title":"J Bone Miner Res"},{"key":"3069_CR24","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.drudis.2013.04.001","volume":"18","author":"MK Robinson","year":"2013","unstructured":"Robinson MK, Caminis J, Brunkow ME (2013) Sclerostin: how human mutations have helped reveal a new target for the treatment of osteoporosis. Drug Discov Today 18:637\u2013643","journal-title":"Drug Discov Today"},{"key":"3069_CR25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1359\/jbmr.090730","volume":"25","author":"I Kramer","year":"2010","unstructured":"Kramer I, Loots GG, Studer A, Keller H, Kneissel M (2010) Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice. J Bone Miner Res 25:178\u2013189","journal-title":"J Bone Miner Res"},{"key":"3069_CR26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00774-010-0202-3","volume":"29","author":"GQ Yao","year":"2011","unstructured":"Yao GQ, Wu JJ, Troiano N, Insogna K (2011) Targeted overexpression of Dkk1 in osteoblasts reduces bone mass but does not impair the anabolic response to intermittent PTH treatment in mice. J Bone Miner Metab 29:141\u2013148","journal-title":"J Bone Miner Metab"},{"key":"3069_CR27","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1073\/pnas.1221255110","volume":"110","author":"ZC Ryan","year":"2013","unstructured":"Ryan ZC, Ketha H, McNulty MS, McGee-Lawrence M, Craig TA, Grande JP, Westendorf JJ, Singh RJ, Kumar R (2013) Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium. Proc Natl Acad Sci U S A 110:6199\u20136204","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3069_CR28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1210\/jc.2013-3168","volume":"99","author":"TC Register","year":"2014","unstructured":"Register TC, Hruska KA, Divers J, Bowden DW, Palmer ND, Carr JJ, Wagenknecht LE, Hightower RC, Xu J, Smith SC, Dietzen DJ, Langefeld CD, Freedman BI (2014) Sclerostin is positively associated with bone mineral density in men and women and negatively associated with carotid calcified atherosclerotic plaque in men from the African American-Diabetes Heart Study. J Clin Endocrinol Metab 99:315\u2013321","journal-title":"J Clin Endocrinol Metab"},{"key":"3069_CR29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1159\/000358303","volume":"60","author":"P Dovjak","year":"2014","unstructured":"Dovjak P, Dorfer S, Foger-Samwald U, Kudlacek S, Marculescu R, Pietschmann P (2014) Serum levels of sclerostin and dickkopf-1: effects of age, gender and fracture status. Gerontology 60:493\u2013501","journal-title":"Gerontology"},{"key":"3069_CR30","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s00223-012-9665-7","volume":"92","author":"O Viapiana","year":"2013","unstructured":"Viapiana O, Fracassi E, Troplini S, Idolazzi L, Rossini M, Adami S, Gatti D (2013) Sclerostin and DKK1 in primary hyperparathyroidism. Calcif Tissue Int 92:324\u2013329","journal-title":"Calcif Tissue Int"},{"key":"3069_CR31","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2011-2152","volume":"97","author":"K Amrein","year":"2012","unstructured":"Amrein K, Amrein S, Drexler C, Dimai HP, Dobnig H, Pfeifer K, Tomaschitz A, Pieber TR, Fahrleitner-Pammer A (2012) Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults. J Clin Endocrinol Metab 97:148\u2013154","journal-title":"J Clin Endocrinol Metab"},{"key":"3069_CR32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jbmr.320","volume":"26","author":"LF Bonewald","year":"2011","unstructured":"Bonewald LF (2011) The amazing osteocyte. J Bone Miner Res 26:229\u2013238","journal-title":"J Bone Miner Res"},{"key":"3069_CR33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.3074","volume":"19","author":"R Baron","year":"2013","unstructured":"Baron R, Kneissel M (2013) WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med 19:179\u2013192","journal-title":"Nat Med"},{"key":"3069_CR34","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","volume":"370","author":"MR McClung","year":"2014","unstructured":"McClung MR, Grauer A, Boonen S, Bolognese MA, Brown JP, Diez-Perez A, Langdahl BL, Reginster JY, Zanchetta JR, Wasserman SM, Katz L, Maddox J, Yang YC, Libanati C, Bone HG (2014) Romosozumab in postmenopausal women with low bone mineral density. N Engl J Med 370:412\u2013420","journal-title":"N Engl J Med"},{"key":"3069_CR35","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1002\/jbmr.474","volume":"26","author":"AH Lierop van","year":"2011","unstructured":"van Lierop AH, Hamdy NA, Hamersma H, van Bezooijen RL, Power J, Loveridge N, Papapoulos SE (2011) Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnover. J Bone Miner Res 26:2804\u20132811","journal-title":"J Bone Miner Res"},{"key":"3069_CR36","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1056\/NEJMc1402396","volume":"370","author":"P Evenepoel","year":"2014","unstructured":"Evenepoel P, D\u2019Haese P, Brandenburg V (2014) Romosozumab in postmenopausal women with osteopenia. N Engl J Med 370:1664","journal-title":"N Engl J Med"},{"key":"3069_CR37","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1582-4934.2007.00201.x","volume":"12","author":"T Nakamura","year":"2008","unstructured":"Nakamura T, Nakamura T, Matsumoto K (2008) The functions and possible significance of Kremen as the gatekeeper of Wnt signalling in development and pathology. J Cell Mol Med 12:391\u2013408","journal-title":"J Cell Mol Med"},{"key":"3069_CR38","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.bone.2013.08.016","volume":"57","author":"L Gifre","year":"2013","unstructured":"Gifre L, Ruiz-Gaspa S, Monegal A, Nomdedeu B, Filella X, Guanabens N, Peris P (2013) Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnover. Bone 57:272\u2013276","journal-title":"Bone"},{"key":"3069_CR39","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S1534-5807(01)00041-7","volume":"1","author":"M Mukhopadhyay","year":"2001","unstructured":"Mukhopadhyay M, Shtrom S, Rodriguez-Esteban C, Chen L, Tsukui T, Gomer L, Dorward DW, Glinka A, Grinberg A, Huang SP, Niehrs C, Izpisua Belmonte JC, Westphal H (2001) Dickkopf1 is required for embryonic head induction and limb morphogenesis in the mouse. Dev Cell 1:423\u2013434","journal-title":"Dev Cell"},{"key":"3069_CR40","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bone.2013.05.010","volume":"56","author":"G Hampson","year":"2013","unstructured":"Hampson G, Edwards S, Conroy S, Blake GM, Fogelman I, Frost ML (2013) The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women. Bone 56:42\u201347","journal-title":"Bone"},{"key":"3069_CR41","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1681\/ASN.2012010097","volume":"24","author":"A Vivante","year":"2013","unstructured":"Vivante A, Mark-Danieli M, Davidovits M, Harari-Steinberg O, Omer D, Gnatek Y, Cleper R, Landau D, Kovalski Y, Weissman I, Eisenstein I, Soudack M, Wolf HR, Issler N, Lotan D, Anikster Y, Dekel B (2013) Renal hypodysplasia associates with a WNT4 variant that causes aberrant canonical WNT signaling. J Am Soc Nephrol 24:550\u2013558","journal-title":"J Am Soc Nephrol"},{"key":"3069_CR42","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1681\/ASN.2009121236","volume":"22","author":"W He","year":"2011","unstructured":"He W, Kang YS, Dai C, Liu Y (2011) Blockade of Wnt\/beta-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury. J Am Soc Nephrol 22:90\u2013103","journal-title":"J Am Soc Nephrol"},{"key":"3069_CR43","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1681\/ASN.2013080818","volume":"25","author":"Y Fang","year":"2014","unstructured":"Fang Y, Ginsberg C, Seifert M, Agapova O, Sugatani T, Register TC, Freedman BI, Monier-Faugere MC, Malluche H, Hruska KA (2014) CKD-induced wingless\/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder. J Am Soc Nephrol 25:1760\u20131773","journal-title":"J Am Soc Nephrol"},{"key":"3069_CR44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1681\/ASN.2014060567","volume":"26","author":"J Floege","year":"2014","unstructured":"Floege J (2014) Antagonism of canonical Wnt\/beta-catenin signaling: taking RAS blockade to the next level? J Am Soc Nephrol 26:3\u20135","journal-title":"J Am Soc Nephrol"},{"key":"3069_CR45","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1093\/ndt\/gfr591","volume":"26","author":"JB Cannata-Andia","year":"2011","unstructured":"Cannata-Andia JB, Roman-Garcia P, Hruska K (2011) The connections between vascular calcification and bone health. Nephrol Dial Transplant 26:3429\u20133436","journal-title":"Nephrol Dial Transplant"},{"key":"3069_CR46","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1471-2369-14-219","volume":"14","author":"VM Brandenburg","year":"2013","unstructured":"Brandenburg VM, Kramann R, Koos R, Kruger T, Schurgers L, Muhlenbruch G, Hubner S, Gladziwa U, Drechsler C, Ketteler M (2013) Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study. BMC Nephrol 14:219","journal-title":"BMC Nephrol"},{"key":"3069_CR47","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1210\/jc.2013-2786","volume":"99","author":"D Cejka","year":"2014","unstructured":"Cejka D, Marculescu R, Kozakowski N, Plischke M, Reiter T, Gessl A, Haas M (2014) Renal elimination of sclerostin increases with declining kidney function. J Clin Endocrinol Metab 99:248\u2013255","journal-title":"J Clin Endocrinol Metab"},{"key":"3069_CR48","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000355781","volume":"39","author":"M Bonani","year":"2014","unstructured":"Bonani M, Rodriguez D, Fehr T, Mohebbi N, Brockmann J, Blum M, Graf N, Frey D, Wuthrich RP (2014) Sclerostin blood levels before and after kidney transplantation. Kidney Blood Press Res 39:230\u2013239","journal-title":"Kidney Blood Press Res"},{"key":"3069_CR49","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jbmr.1630","volume":"27","author":"Y Sabbagh","year":"2012","unstructured":"Sabbagh Y, Graciolli FG, O\u2019Brien S, Tang W, dos Reis LM, Ryan S, Phillips L, Boulanger J, Song W, Bracken C, Liu S, Ledbetter S, Dechow P, Canziani ME, Carvalho AB, Jorgetti V, Moyses RM, Schiavi SC (2012) Repression of osteocyte Wnt\/beta-catenin signaling is an early event in the progression of renal osteodystrophy. J Bone Miner Res 27:1757\u20131772","journal-title":"J Bone Miner Res"},{"key":"3069_CR50","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1093\/ndt\/gft039","volume":"28","author":"L Viaene","year":"2013","unstructured":"Viaene L, Behets GJ, Claes K, Meijers B, Blocki F, Brandenburg V, Evenepoel P, D\u2019Haese PC (2013) Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis? Nephrol Dial Transplant 28:3024\u20133030","journal-title":"Nephrol Dial Transplant"},{"key":"3069_CR51","author":"C Drechsler","year":"2014","unstructured":"Drechsler C, Evenepoel P, Vervloet MG, Wanner C, Ketteler M, Marx N, Floege J, Dekker FW, Brandenburg VM (2014) High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD study. Nephrol Dial Transplant. doi: 10.1093\/ndt\/gfu301","journal-title":"Nephrol Dial Transplant"},{"key":"3069_CR52","doi-asserted-by":"crossref","first-page":"E1854","DOI":"10.1210\/jc.2014-2042","volume":"99","author":"M Kanbay","year":"2014","unstructured":"Kanbay M, Siriopol D, Saglam M, Gulcan KY, Gok M, Cetinkaya H, Karaman M, Umut UH, Oguz Y, Sari S, Eyileten T, Goldsmith D, Vural A, Veisa G, Covic A, Ilker YM (2014) Serum sclerostin and adverse outcomes in non-dialyzed chronic kidney disease patients. J Clin Endocrinol Metab 99:E1854\u2013E1861","journal-title":"J Clin Endocrinol Metab"},{"key":"3069_CR53","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.bone.2012.09.016","volume":"54","author":"T Bellido","year":"2013","unstructured":"Bellido T, Saini V, Pajevic PD (2013) Effects of PTH on osteocyte function. Bone 54:250\u2013257","journal-title":"Bone"},{"key":"3069_CR54","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2005.03.018","volume":"37","author":"H Keller","year":"2005","unstructured":"Keller H, Kneissel M (2005) SOST is a target gene for PTH in bone. Bone 37:148\u2013158","journal-title":"Bone"},{"key":"3069_CR55","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1210\/jc.2013-2113","volume":"98","author":"C Durosier","year":"2013","unstructured":"Durosier C, van Lierop A, Ferrari S, Chevalley T, Papapoulos S, Rizzoli R (2013) Association of circulating sclerostin with bone mineral mass, microstructure, and turnover biochemical markers in healthy elderly men and women. J Clin Endocrinol Metab 98:3873\u20133883","journal-title":"J Clin Endocrinol Metab"},{"key":"3069_CR56","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/jbmr.1962","volume":"28","author":"C Li","year":"2013","unstructured":"Li C, Xing Q, Yu B, Xie H, Wang W, Shi C, Crane JL, Cao X, Wan M (2013) Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH. J Bone Miner Res 28:2094\u20132108","journal-title":"J Bone Miner Res"},{"key":"3069_CR57","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5301\/jn.5000212","volume":"26","author":"JB Cannata-Andia","year":"2013","unstructured":"Cannata-Andia JB, Rodriguez GM, Gomez AC (2013) Osteoporosis and adynamic bone in chronic kidney disease. J Nephrol 26:73\u201380","journal-title":"J Nephrol"},{"key":"3069_CR58","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2215\/CJN.06550810","volume":"6","author":"D Cejka","year":"2011","unstructured":"Cejka D, Herberth J, Branscum AJ, Fardo DW, Monier-Faugere MC, Diarra D, Haas M, Malluche HH (2011) Sclerostin and Dickkopf-1 in renal osteodystrophy. Clin J Am Soc Nephrol 6:877\u2013882","journal-title":"Clin J Am Soc Nephrol"},{"key":"3069_CR59","doi-asserted-by":"crossref","first-page":"e79721","DOI":"10.1371\/journal.pone.0079721","volume":"8","author":"JC Ferreira","year":"2013","unstructured":"Ferreira JC, Ferrari GO, Neves KR, Cavallari RT, Dominguez WV, dos Reis LM, Graciolli FG, Oliveira EC, Liu S, Sabbagh Y, Jorgetti V, Schiavi S, Moyses RM (2013) Effects of dietary phosphate on adynamic bone disease in rats with chronic kidney disease\u2013role of sclerostin? PLoS One 8:e79721","journal-title":"PLoS One"},{"key":"3069_CR60","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.tem.2012.06.001","volume":"23","author":"K Marinou","year":"2012","unstructured":"Marinou K, Christodoulides C, Antoniades C, Koutsilieris M (2012) Wnt signaling in cardiovascular physiology. Trends Endocrinol Metab 23:628\u2013636","journal-title":"Trends Endocrinol Metab"},{"key":"3069_CR61","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.numecd.2009.08.004","volume":"21","author":"R Sarzani","year":"2011","unstructured":"Sarzani R, Salvi F, Bordicchia M, Guerra F, Battistoni I, Pagliariccio G, Carbonari L, Dessi-Fulgheri P, Rappelli A (2011) Carotid artery atherosclerosis in hypertensive patients with a functional LDL receptor-related protein 6 gene variant. Nutr Metab Cardiovasc Dis 21:150\u2013156","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"3069_CR62","first-page":"648","volume":"23","author":"M Cozzolino","year":"2010","unstructured":"Cozzolino M, Brandenburg V (2010) Warfarin: to use or not to use in chronic kidney disease patients? J Nephrol 23:648\u2013652","journal-title":"J Nephrol"},{"key":"3069_CR63","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1161\/ATVBAHA.113.302244","volume":"33","author":"T Kruger","year":"2013","unstructured":"Kruger T, Oelenberg S, Kaesler N, Schurgers LJ, van de Sandt AM, Boor P, Schlieper G, Brandenburg VM, Fekete BC, Veulemans V, Ketteler M, Vermeer C, Jahnen-Dechent W, Floege J, Westenfeld R (2013) Warfarin induces cardiovascular damage in mice. Arterioscler Thromb Vasc Biol 33:2618\u20132624","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3069_CR64","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/ATVBAHA.111.237834","volume":"32","author":"KE Beazley","year":"2012","unstructured":"Beazley KE, Deasey S, Lima F, Nurminskaya MV (2012) Transglutaminase 2-mediated activation of beta-catenin signaling has a critical role in warfarin-induced vascular calcification. Arterioscler Thromb Vasc Biol 32:123\u2013130","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3069_CR65","doi-asserted-by":"crossref","first-page":"e19595","DOI":"10.1371\/journal.pone.0019595","volume":"6","author":"D Zhu","year":"2011","unstructured":"Zhu D, Mackenzie NC, Millan JL, Farquharson C, MacRae VE (2011) The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells. PLoS One 6:e19595","journal-title":"PLoS One"},{"key":"3069_CR66","first-page":"317","volume":"22","author":"R Koos","year":"2013","unstructured":"Koos R, Brandenburg V, Mahnken AH, Schneider R, Dohmen G, Autschbach R, Marx N, Kramann R (2013) Sclerostin as a potential novel biomarker for aortic valve calcification: an in-vivo and ex-vivo study. J Heart Valve Dis 22:317\u2013325","journal-title":"J Heart Valve Dis"},{"key":"3069_CR67","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/ndt\/gfs466","volume":"28","author":"R Kramann","year":"2013","unstructured":"Kramann R, Brandenburg VM, Schurgers LJ, Ketteler M, Westphal S, Leisten I, Bovi M, Jahnen-Dechent W, Knuchel R, Floege J, Schneider RK (2013) Novel insights into osteogenesis and matrix remodelling associated with calcific uraemic arteriolopathy. Nephrol Dial Transplant 28:856\u2013868","journal-title":"Nephrol Dial Transplant"},{"key":"3069_CR68","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1210\/jc.2013-1521","volume":"98","author":"KJ Claes","year":"2013","unstructured":"Claes KJ, Viaene L, Heye S, Meijers B, D\u2019Haese P, Evenepoel P (2013) Sclerostin: another vascular calcification inhibitor? J Clin Endocrinol Metab 98:3221\u20133228","journal-title":"J Clin Endocrinol Metab"},{"key":"3069_CR69","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jbmr.217","volume":"26","author":"UI Modder","year":"2011","unstructured":"Modder UI, Hoey KA, Amin S, McCready LK, Achenbach SJ, Riggs BL, Melton LJ III, Khosla S (2011) Relation of age, gender, and bone mass to circulating sclerostin levels in women and men. J Bone Miner Res 26:373\u2013379","journal-title":"J Bone Miner Res"},{"key":"3069_CR70","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1258\/acb.2012.011274","volume":"49","author":"DC Fischer","year":"2012","unstructured":"Fischer DC, Mischek A, Wolf S, Rahn A, Salweski B, Kundt G, Haffner D (2012) Paediatric reference values for the C-terminal fragment of fibroblast-growth factor-23, sclerostin, bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase. Ann Clin Biochem 49:546\u2013553","journal-title":"Ann Clin Biochem"},{"key":"3069_CR71","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00198-011-1669-z","volume":"23","author":"S Kirmani","year":"2012","unstructured":"Kirmani S, Amin S, McCready LK, Atkinson EJ, Melton LJ III, Muller R, Khosla S (2012) Sclerostin levels during growth in children. Osteoporos Int 23:1123\u20131130","journal-title":"Osteoporos Int"},{"key":"3069_CR72","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1210\/jc.2010-0720","volume":"95","author":"MT Drake","year":"2010","unstructured":"Drake MT, Srinivasan B, Modder UI, Peterson JM, McCready LK, Riggs BL, Dwyer D, Stolina M, Kostenuik P, Khosla S (2010) Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women. J Clin Endocrinol Metab 95:5056\u20135062","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-015-3069-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-015-3069-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-015-3069-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T16:21:06Z","timestamp":1566404466000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-015-3069-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,4]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["3069"],"URL":"https:\/\/doi.org\/10.1007\/s00467-015-3069-7","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,4]]}}}